Find similiar products:
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL 25258/0235 .
Atovaquone Glenmark 750 mg/5 ml oral suspension
Atovaquone Glenmark 750 mg/5 ml oral suspension
Atovaquone
1. What Atovaquone Glenmark 750mg/5ml oral suspension is and what it is used for
2. What you need to know before you take Atovaquone Glenmark 750mg/5ml oral suspension
3. How to take Atovaquone Glenmark 750mg/5ml oral suspension
4. Possible side effects
5. How to store Atovaquone Glenmark 750mg/5ml oral suspension
6. Contents of the pack and other information
Atovaquone Glenmark 750mg/5ml oral suspension is used to treat a lung infection called Pneumocystis pneumonia (PCP) in people who cannot take the medicine co-trimoxazole.
This disease is caused by an organism called Pneumocystis jiroveci (which used to be called Pneumocystis carinii).
The active ingredient in Atovaquone Glenmark 750mg/5ml oral suspension is atovaquone. Atovaquone Glenmark 750mg/5ml oral suspension belongs to a group of anti-parasitic medicines known as antiprotozoals.
Talk to your doctor or pharmacist before taking Atovaquone Glenmark 750mg/5ml oral suspension
Take special care with Atovaquone Glenmark 750mg/5ml oral suspension
Your doctor needs to know before you take Atovaquone Glenmark 750mg/5ml oral suspension:
Tell your doctor or pharmacist if you’re taking, have recently taken any other medicines, including any herbal medicines or other medicines you’ve bought without a prescription.
Some medicines can reduce the effectiveness of Atovaquone, or Atovaquone itself can change the effect of other medicines taken at the same time. These include:
Tell your doctor if you are taking any of these. Your doctor may decide that Atovaquone Glenmark 750mg/5ml oral suspension isn’t suitable for you, or that you need extra check-ups while you’re taking it.
Remember to tell your doctor if you start taking any other medicine while you’re taking Atovaquone Glenmark 750mg/5ml oral suspension.
Always take Atovaquone Glenmark 750mg/5ml oral suspension with food - preferably foods that are high in fat. This will increase the amount of Atovaquone Glenmark 750mg/5ml oral suspension that your body can absorb, and make your treatment more effective.
Ask your doctor for advice about which foods are suitable.
If you have difficulty in taking Atovaquone Glenmark 750mg/5ml oral suspension with food, talk to your doctor about alternative treatments.
Your ability to drive or use machinery is not expected to be affected while you’re taking Atovaquone Glenmark 750mg/5ml oral suspension.
This medicine contains 50.00 mg benzyl alcohol in each 5 ml.
Benzyl alcohol may cause allergic reactions.
Benzyl alcohol has been linked with the risk of severe side effects including breathing problems (called “gasping syndrome”) in young children. Do not give to your newborn baby (up to 4 weeks old), unless recommended by your doctor.
Do not use for more than a week in young children (less than 3 years old), unless advised by your doctor or pharmacist.
Ask your doctor or pharmacist for advice if you are pregnant or breast-feeding or if you have a liver or kidney disease. This is because large amounts of benzyl alcohol can build-up in your body and may cause side effects (called “metabolic acidosis”).
This medicine contains less than 1 mmol sodium (23 mg) in each 5 ml, that is to say essentially ‘sodium free’.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you’re not sure.
Shake the bottle well before use.
Do not dilute Atovaquone Glenmark 750mg/5ml oral suspension.
Always take Atovaquone Glenmark 750mg/5ml oral suspension with food - preferably foods which are high in fat. This will greatly increase the amount of Atovaquone Glenmark 750mg/5ml oral suspension absorbed, and will make your treatment more effective.
The recommended adult dose of Atovaquone Glenmark 750mg/5ml oral suspension is one 5 ml spoonful (containing 750 mg atovaquone), twice a day for 21 days.
Take one dose in the morning and one in the evening.
Contact your doctor or pharmacist for advice. If possible, show them the Atovaquone Glenmark 750mg/5ml oral suspension pack.
If you forget to take a dose of Atovaquone Glenmark 750mg/5ml oral suspension, take the next dose as soon as you remember (again with food), and then continue the treatment as before. Do not take a double dose to make up for a forgotten dose.
Don’t stop Atovaquone Glenmark 750mg/5ml oral suspension without advice.
Take Atovaquone Glenmark 750mg/5ml oral suspension for as long as your doctor recommends. Don’t stop unless your doctor advises you to - even if you are feeling better. If you do not complete the full course of treatment, the infection may come back.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common side effects
These may affect more than 1 in 10 people:
Common side effects
These may affect up to 1 in 10 people:
Other common side effects, which may show up in blood tests, are:
Uncommon side effects
These may affect up to 1 in 100 people:
Other side effects have occurred in a very small number of people but their exact frequency is unknown:
If you notice any of these symptoms contact a doctor urgently.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label of the bottle. Once opened use within 21 days.
This medicinal product does not require any special storage conditions. Do not refrigerate or freeze.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. This will help protect the environment.
Atovaquone Glenmark 750mg/5ml oral suspension oral suspension is a yellow liquid. The medicine is contained in a plastic bottle with child -resistant cap, containing 226 ml oral suspension.
A 5ml measuring spoon is included in each pack.
Marketing Authorisation Holder:
Manufacturer:
Glenmark Pharmaceuticals s.r.o.
Production site address:
Registered Address:
This medicinal product is authorised in the Member States of the EEA under the following names:
UK: Atovaquone Glenmark 750 mg/5 ml oral suspension
NL: Atovaquon Glenmark 750 mg/5 ml suspensie voor oraal gebruik
PT: Atovaquona Kabi
DE: Atovaquon Glenmark 750 mg/5 ml Suspension zum Einnehmen
DK: Atovaquone Glenmark
ES: Atovacuona Glenmark 750 mg/5 ml suspensión oral EFG
FI: Atovaquone Glenmark
SE: Atovaquone Glenmark
NO: Atovaquone Glenmark
FR: Atovaquone Biogaran 750 mg/5ml, suspension buvable
IT: Atovquone Glenmark
This leaflet was last revised in 01/2022